US5519003AExpiredUtility

WD-40-derived peptides and uses thereof

79
Assignee: UNIV LELAND STANFORD JUNIORPriority: Feb 1, 1994Filed: Feb 1, 1994Granted: May 21, 1996
Est. expiryFeb 1, 2014(expired)· nominal 20-yr term from priority
C07K 14/00C07K 5/1024C07K 14/4722C07K 14/705
79
PatentIndex Score
40
Cited by
28
References
1
Claims

Abstract

The present invention relates to a polypeptide composition effective to alter the activity of a first protein that interacts with a second protein, where the second protein contains at least one WD-40 region. The polypeptides of the present invention typically have between 4 and 50 amino acids whose sequence is the same as a sequence of the same length in the WD-40 region of the second protein. The invention further includes a method of altering the activity of the above described first protein. In one embodiment of the invention the polypeptide composition is effective to alter the activity of a protein kinase C, where the protein kinase C interacts with a second protein, and the second protein contains at least one WD-40 region (e.g., RACK1).

Claims

exact text as granted — not AI-modified
It is claimed: 
     
       1. A method of altering the activity of a protein kinase C that interacts with a second protein, where the second protein contains at least one WD-40 region, comprising contacting a polypeptide which has an amino acid sequence represented by SEQ ID NO:4 or SEQ ID NO:7 with said protein kinase C under conditions which allow the formation of a complex between the polypeptide and the protein kinase C, where the formation of said complex inhibits the interaction between said protein kinase C and said second protein; or contacting a polypeptide which has the amino acid sequence represented by SEQ ID NO:7 with said protein kinase C under conditions which allow the formation of a complex between the polypeptide and the protein kinase C, where the formation of said complex stimulates the activity of said protein kinase C.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.